1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Complete Atypical DiGeorge Anomaly: new trials by email Literature Review of Complete Atypical DiGeorge Anomaly trials Research Report on Complete Atypical DiGeorge Anomaly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Thymus Transplantation With Immunosuppression #950 Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Switzerland GmbH | 14 | 2005-12-19 | 2022-03-25 |
DiGeorge Syndrome (1) · Hypocalcemia (1) · Hypoparathyroidism (1) · Immunologic Deficiency Syndromes (1) · Thymic aplasia (1)
22q11 Deletion Syndrome (1) · Abnormalities, Multiple (1) · Calcium Metabolism Disorders (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1)
Antilymphocyte Serum (1) · Blood Specimen Collection (1) · Cyclosporine (1) · Cyclosporins (1) · Daclizumab (1) · Drug Implants (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Phlebotomy (1) · Prednisolone (1) · Steroids (1) · Tacrolimus (1) · Thymus Extracts (1) · thymoglobulin (1)
Sumitomo Pharma Switzerland GmbH (1)
United States (1)
M. Louise Markert, MD, PhD (1)
PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606
K12HD043494 (1), R01AI047040 (1), R01AI054843 (1)